Beth Gates

Beth Gates serves as the Associate Director of Strategic Planning & Operations for Global & US Oncology Medical Affairs at Eisai US since September 2022, where responsibilities include managing project timelines, budgets, and strategic alliances. Previously, during tenure at HUTCHMED US Corporation, Beth established marketing compliance processes and led launch readiness for the NDA of surufatinib. As a Vice President at VMLY&R Healthcare Communications, Beth managed a $5M portfolio, executing communication strategies and ensuring adherence to compliance regulations while leading cross-functional teams. Beth is also an advisory committee member of the VMLY&R Foundation, contributing to charitable initiatives, and holds a Bachelor of Arts in Economics from Brandeis University.